Theriva Biologics, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Theriva Biologics, Inc. (TOVX) had Stockholders' Equity Attributable to Noncontrolling Interest of -$2.77 million as of 2021-09-30, per its 10-Q filed 2021-11-03.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2022-03-16
- 2021-09-30: Stockholders' Equity Attributable to Noncontrolling Interest -$2.77M.
- 2021-06-30: Stockholders' Equity Attributable to Noncontrolling Interest -$2.77M.
- 2021-03-31: Stockholders' Equity Attributable to Noncontrolling Interest -$2.77M.
- 2020-12-31: Stockholders' Equity Attributable to Noncontrolling Interest -$2.77M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2021-09-30 | -$2.77M 10-Q · filed 2021-11-03 |
| 2021-06-30 | -$2.77M 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$2.77M 10-Q · filed 2021-05-05 |
| 2020-12-31 | -$2.77M 10-K · filed 2022-03-16 |
| 2020-09-30 | -$2.75M 10-Q · filed 2020-11-10 |
| 2020-06-30 | -$2.88M 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$2.88M 10-Q · filed 2020-05-05 |
| 2019-12-31 | -$2.88M 10-K · filed 2021-03-04 |
| 2019-09-30 | -$2.84M 10-Q · filed 2019-11-04 |
| 2019-06-30 | -$2.85M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$2.87M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$2.91M 10-K · filed 2020-02-20 |
| 2018-09-30 | -$1.95M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$1.94M 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$1.92M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$1.91M 10-K · filed 2019-02-27 |
| 2017-09-30 | -$1.88M 10-Q · filed 2017-11-01 |
| 2017-06-30 | -$1.87M 10-Q · filed 2017-08-03 |
| 2017-03-31 | -$1.81M 10-Q · filed 2017-05-04 |
| 2016-12-31 | -$1.60M 10-K · filed 2018-02-22 |
| 2016-09-30 | -$1.50M 10-Q · filed 2016-11-01 |
| 2016-06-30 | -$1.36M 10-Q · filed 2016-08-03 |
| 2016-03-31 | -$1.28M 10-Q · filed 2016-05-05 |
| 2015-12-31 | -$1.05M 10-K · filed 2017-03-02 |
| 2015-09-30 | -$733.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-10 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-14 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |